The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-Linking
Abstract
Age-associated increases in collagen cross-linking and accumulation of advanced glycosylation products are both accelerated by diabetes, suggesting that glucose-derived cross-link formation may contribute to the development of chronic diabetic complications as well as certain physical changes of aging. Aminoguanidine, a nucleophilic hydrazine compound, prevented both the formation of fluorescent advanced nonenzymatic glycosylation products and the formation of glucose-derived collagen cross-links in vitro. Aminoguanidine administration to rats was equally effective in preventing diabetes-induced formation of fluorescent advanced nonenzymatic glycosylation products and cross-linking of arterial wall connective tissue protein in vivo. The identification of aminoguanidine as an inhibitor of advanced nonenzymatic glycosylation product formation now makes possible precise experimental definition of the pathogenetic significance of this process and suggests a potential clinical role for aminoguanidine in the future treatment of chronic diabetic complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels
Oakley, B. R., Kirsch, D. R., & Morris, N. R. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90470-4 · Cited by 3,247
Determination of hydroxyproline
Stegemann, H., & Stalder, K. (1967) · Clinica Chimica Acta · doi:10.1016/0009-8981(67)90167-2 · Cited by 1,570
Nonenzymatic Browning in Vivo: Possible Process for Aging of Long-Lived Proteins
Monnier, V. M., & Cerami, A. (1981) · Science · doi:10.1126/science.6779377 · Cited by 764
Self-citation[2] Preparation and characterization of the different types of collagen
Miller, E. J., & Kent Rhodes, R. (1982) · Methods in Enzymology · doi:10.1016/0076-6879(82)82059-4 · Cited by 752
Accelerated age-related browning of human collagen in diabetes mellitus.
Monnier, V. M., Kohn, R. R., & Cerami, A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.2.583 · Cited by 671
Self-citationReisner, A. H., Nemes, P., & Bucholtz, C. (1975) · Analytical Biochemistry · doi:10.1016/0003-2697(75)90461-3 · Cited by 615
Pongor, S., Ulrich, P. C., Bencsath, F. A., & Cerami, A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.9.2684 · Cited by 373
Self-citationChandrakasan, G., Torchia, D. A., & Piez, K. A. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33059-4 · Cited by 362
Schnider, S. L., & Kohn, R. R. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110198 · Cited by 312
Cited by
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
Flier, J. S., Underhill, L. H., Brownlee, M., Cerami, A., & Vlassara, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805193182007 · Cited by 2,511
Self-citationAdvanced protein glycosylation in diabetes and aging
Brownlee, M. D. (1995) · Annual Review of Medicine · doi:10.1146/annurev.med.46.1.223 · Cited by 1,312
Self-citationBucala, R., Tracey, K. J., & Cerami, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115014 · Cited by 1,165
Self-citationStructure Elucidation of a Senescence Cross-Link from Human Extracellular Matrix
Sell, D. R., & Monnier, V. M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)88225-8 · Cited by 1,081
Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications
Sheetz, M. J. (2002) · JAMA · doi:10.1001/jama.288.20.2579 · Cited by 1,002
BASTA, G. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.05.001 · Cited by 999
The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
Goh, S.-Y., & Cooper, M. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1817 · Cited by 987
The aging of the immune system
Weiskopf, D., Weinberger, B., & Grubeck-Loebenstein, B. (2009) · Transplant International · doi:10.1111/j.1432-2277.2009.00927.x · Cited by 908
Frank, R. N. (2004) · New England Journal of Medicine · doi:10.1056/nejmra021678 · Cited by 891
Control of Maillard Reactions in Foods: Strategies and Chemical Mechanisms
Lund, M. N., & Ray, C. A. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b00882 · Cited by 871
Fu, M.-X., Requena, J. R., Jenkins, A. J., Lyons, T. J., Baynes, J. W., & Thorpe, S. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.9982 · Cited by 822
Advanced glycation end products contribute to amyloidosis in Alzheimer disease
Vitek, M. P., Bhattacharya, K., Glendening, J. M., Stopa, E., Vlassara, H., Bucala, R., Manogue, K., & Cerami, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4766 · Cited by 806
Self-citationNew Aspects of the Maillard Reaction in Foods and in the Human Body
Ledl, F., & Schleicher, E. (1990) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199005653 · Cited by 738
Advanced Maillard reaction end products are associated with Alzheimer disease pathology.
Smith, M. A., Taneda, S., Richey, P. L., Miyata, S., Yan, S. D., Stern, D., Sayre, L. M., Monnier, V. M., & Perry, G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5710 · Cited by 714
Diabetes and advanced glycation endproducts
Vlassara, H., & Palace, M. R. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00932.x · Cited by 697
Self-citationUse of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts
Thornalley, P. J. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.013 · Cited by 682
Mechanisms of maturation and ageing of collagen
Bailey, A. J., Paul, R. G., & Knott, L. (1998) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(98)00119-5 · Cited by 672
Chaudhuri, J., Bains, Y., Guha, S., Kahn, A., Hall, D., Bose, N., Gugliucci, A., & Kapahi, P. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.08.014 · Cited by 669
Vlassara, H., Cai, W., Crandall, J., Goldberg, T., Oberstein, R., Dardaine, V., Peppa, M., & Rayfield, E. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242407999 · Cited by 668
Self-citationAronson, D. (2003) · Journal of Hypertension · doi:10.1097/00004872-200301000-00002 · Cited by 651
Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction
Corbett, J. A., Tilton, R. G., Chang, K., Hasan, K. S., Ido, Y., Wang, J. L., Sweetland, M. A., Lancaster, J. R., Williamson, J. R., & McDaniel, M. L. (1992) · Diabetes · doi:10.2337/diab.41.4.552 · Cited by 628
Schalkwijk, C. G., & Stehouwer, C. D. A. (2020) · Physiological Reviews · doi:10.1152/physrev.00001.2019 · Cited by 622
Kern, T. S. (2007) · Journal of Diabetes Research · doi:10.1155/2007/95103 · Cited by 614
Wells-Knecht, K. J., Zyzak, D. V., Litchfield, J. E., Thorpe, S. R., & Baynes, J. W. (1995) · Biochemistry · doi:10.1021/bi00011a027 · Cited by 595
Thornalley, P. J. (1996) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(95)02054-3 · Cited by 591
Glomb, M. A., & Monnier, V. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.10017 · Cited by 576
Glyoxalase System in Clinical Diabetes Mellitus and Correlation with Diabetic Complications
McLellan, A. C., Thornalley, P. J., Benn, J., & Sonksen, P. H. (1994) · Clinical Science · doi:10.1042/cs0870021 · Cited by 557
Bierhaus, A. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00233-2 · Cited by 555
Dyer, D. G., Blackledge, J. A., Thorpe, S. R., & Baynes, J. W. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99007-1 · Cited by 535
The glyoxalase system in health and disease
Thornalley, P. J. (1993) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(93)90002-u · Cited by 533
Advanced Glycosylation: Chemistry, Biology, and Implications for Diabetes and Aging
Bucala, R., & Cerami, A. (1992) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60961-8 · Cited by 526
Self-citationAminoguanidine treatment inhibits the development of experimental diabetic retinopathy.
Hammes, H. P., Martin, S., Federlin, K., Geisen, K., & Brownlee, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11555 · Cited by 524
Self-citationMiyata, T., van Ypersele de Strihou, C., Kurokawa, K., & Baynes, J. W. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00302.x · Cited by 518
Glycoxidation and lipoxidation in atherogenesis
Baynes, J. W., & Thorpe, S. R. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00228-8 · Cited by 514
How hyperglycemia promotes atherosclerosis: molecular mechanisms
Aronson, D., & Rayfield, E. J. (2002) · Cardiovascular Diabetology · doi:10.1186/1475-2840-1-1 · Cited by 504
Immunochemical detection of advanced glycosylation end products in vivo.
Makita, Z., Vlassara, H., Cerami, A., & Bucala, R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42741-x · Cited by 491
Self-citationBucala, R., Makita, Z., Vega, G., Grundy, S., Koschinsky, T., Cerami, A., & Vlassara, H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9441 · Cited by 474
Self-citationBaking, Ageing, Diabetes: A Short History of the Maillard Reaction
Hellwig, M., & Henle, T. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201308808 · Cited by 467
Antioxidative and Anti-Glycation Activity of Garcinol from Garcinia indica Fruit Rind
Yamaguchi, F., Ariga, T., Yoshimura, Y., & Nakazawa, H. (2000) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf990845y · Cited by 448
Age-related vascular stiffening: causes and consequences
Kohn, J. C., Lampi, M. C., & Reinhart-King, C. A. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00112 · Cited by 440
“Recent data suggest numerous cell types respond to matrix stiffness and that stiffness can promote stem cell differentiation, tissue morphogenesis, and tumor malignancy (Paszek and Weaver, 2004; Sieminski et al., 2004; Paszek et al., 2005; Engler et al., 2006).”
BackgroundMcCance, D. R., Dyer, D. G., Dunn, J. A., Bailie, K. E., Thorpe, S. R., Baynes, J. W., & Lyons, T. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116482 · Cited by 444
Abnormalities of Retinal Metabolism in Diabetes and Experimental Galactosemia
Kowluru, R. A., Tang, J., & Kern, T. S. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1938 · Cited by 435
Breakers of advanced glycation end products restore large artery properties in experimental diabetes
Wolffenbuttel, B. H. R., Boulanger, C. M., Crijns, F. R. L., Huijberts, M. S. P., Poitevin, P., Swennen, G. N. M., Vasan, S., Egan, J. J., Ulrich, P., Cerami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4630 · Cited by 434
Self-citationGeorge Lyman Duff Memorial Lecture. Atherogenesis in diabetes.
Bierman, E. L. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.6.647 · Cited by 413
Ashraf, J. M., Ansari, M. A., Khan, H. M., Alzohairy, M. A., & Choi, I. (2016) · Scientific Reports · doi:10.1038/srep20414 · Cited by 404
Advanced glycation end products and the kidney
Bohlender, J. M., Franke, S., Stein, G., & Wolf, G. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00398.2004 · Cited by 387
Cross, A. H., Misko, T. P., Lin, R. F., Hickey, W. F., Trotter, J. L., & Tilton, R. G. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117282 · Cited by 384
Esposito, C., Gerlach, H., Brett, J., Stern, D., & Vlassara, H. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.4.1387 · Cited by 380
Self-citationPyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat
Degenhardt, T. P., Alderson, N. L., Arrington, D. D., Beattie, R. J., Basgen, J. M., Steffes, M. W., Thorpe, S. R., & Baynes, J. W. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00207.x · Cited by 378
Vlassara, H., Fuh, H., Makita, Z., Krungkrai, S., Cerami, A., & Bucala, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12043 · Cited by 377
Self-citationNeufeld, A. H., Sawada, A., & Becker, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9944 · Cited by 374
AGE, RAGE, and ROS in Diabetic Nephropathy
Tan, A. L. Y., Forbes, J. M., & Cooper, M. E. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.01.006 · Cited by 368
Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms
Stirban, A., Gawlowski, T., & Roden, M. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2013.11.006 · Cited by 361
Oxidative Stress: Signaling Pathways, Biological Functions, and Disease
Liu, S., Liu, J., Wang, Y., Deng, F., & Deng, Z. (2025) · MedComm · doi:10.1002/mco2.70268 · Cited by 359
Matsuoka, T., Kajimoto, Y., Watada, H., Kaneto, H., Kishimoto, M., Umayahara, Y., Fujitani, Y., Kamada, T., Kawamori, R., & Yamasaki, Y. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119126 · Cited by 359
Paul, R. G., & Bailey, A. J. (1996) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00079-9 · Cited by 359
Byun, K., Yoo, Y., Son, M., Lee, J., Jeong, G.-B., Park, Y. M., Salekdeh, G. H., & Lee, B. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.030 · Cited by 357
The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases
Maessen, D. E. M., Stehouwer, C. D. A., & Schalkwijk, C. G. (2015) · Clinical Science · doi:10.1042/cs20140683 · Cited by 334
Diabetes and Advanced Glycoxidation End Products
Huebschmann, A. G., Regensteiner, J. G., Vlassara, H., & Reusch, J. E. B. (2006) · Diabetes Care · doi:10.2337/dc05-2096 · Cited by 330
Self-citationNovel inhibitors of advanced glycation endproducts
Rahbar, S., & Figarola, J. L. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.009 · Cited by 329
Role of fructose in glycation and cross-linking of proteins
McPherson, J. D., Shilton, B. H., & Walton, D. J. (1988) · Biochemistry · doi:10.1021/bi00406a016 · Cited by 328
Inhibition of advanced glycation endproduct formation by foodstuffs
Wu, C.-H., Huang, S.-M., Lin, J.-A., & Yen, G.-C. (2011) · Food & Function · doi:10.1039/c1fo10026b · Cited by 328
Nakayama, M., Kawaguchi, Y., Yamada, K., Hasegawa, T., Takazoe, K., Katoh, N., Hayakawa, H., Osaka, N., Yamamoto, H., Ogawa, A., et al. (1997) · Kidney International · doi:10.1038/ki.1997.22 · Cited by 316
Advanced Glycation End Product Interventions Reduce Diabetes-Accelerated Atherosclerosis
Forbes, J. M., Yee, L. T. L., Thallas, V., Lassila, M., Candido, R., Jandeleit-Dahm, K. A., Thomas, M. C., Burns, W. C., Deemer, E. K., Thorpe, S. R., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1813 · Cited by 314
Arterial stiffness in diabetes mellitus
Prenner, S. B., & Chirinos, J. A. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.12.023 · Cited by 313
Rapid gut dysbiosis induced by stroke exacerbates brain infarction in turn
Xu, K., Gao, X., Xia, G., Chen, M., Zeng, N., Wang, S., You, C., Tian, X., Di, H., Tang, W., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-323263 · Cited by 308
Chelating Activity of Advanced Glycation End-product Inhibitors
Price, D. L., Rhett, P. M., Thorpe, S. R., & Baynes, J. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108196200 · Cited by 308
Advanced glycation: an important pathological event in diabetic and age related ocular disease
STITT, A. W. (2001) · British Journal of Ophthalmology · doi:10.1136/bjo.85.6.746 · Cited by 306
Hayase, F., Nagaraj, R. H., Miyata, S., Njoroge, F. G., & Monnier, V. M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84914-1 · Cited by 306
Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets
Dewanjee, S., Das, S., Das, A. K., Bhattacharjee, N., Dihingia, A., Dua, T. K., Kalita, J., & Manna, P. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.06.034 · Cited by 300
The AGE‐receptor in the pathogenesis of diabetic complications
Vlassara, H. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.233 · Cited by 301
Self-citationAdvanced glycation end products up-regulate gene expression found in diabetic glomerular disease.
Yang, C. W., Vlassara, H., Peten, E. P., He, C. J., Striker, G. E., & Striker, L. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9436 · Cited by 294
Self-citationResponse to Periodontal Therapy in Diabetics and Smokers
Grossi, S. G., Skrepcinski, F. B., DeCaro, T., Zambon, J. J., Cummins, D., & Genco, R. J. (1996) · Journal of Periodontology · doi:10.1902/jop.1996.67.10s.1094 · Cited by 293
THE CELLULAR AND MOLECULAR MECHANISMS OF DIABETIC COMPLICATIONS
King, G. L., & Brownlee, M. (1996) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70324-8 · Cited by 290
Self-citationAdvanced glycation end products: A nephrologist's perspective
Raj, D. S. C., Choudhury, D., Welbourne, T. C., & Levi, M. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70189-2 · Cited by 290
Miyata, T., van Ypersele de Strihou, C., Ueda, Y., Ichimori, K., Inagi, R., Onogi, H., Ishikawa, N., Nangaku, M., & Kurokawa, K. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000032418.67267.f2 · Cited by 290
Intervention strategies to inhibit protein carbonylation by lipoxidation‐derived reactive carbonyls
Aldini, G., Dalle‐Donne, I., Facino, R. M., Milzani, A., & Carini, M. (2007) · Medicinal Research Reviews · doi:10.1002/med.20073 · Cited by 289
In Vitro Kinetic Studies of Formation of Antigenic Advanced Glycation End Products (AGEs)
Booth, A. A., Khalifah, R. G., Todd, P., & Hudson, B. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5430 · Cited by 286
Role of the Maillard Reaction in Diabetes Mellitus and Diseases of Aging
Thorpe, S. R., & Baynes, J. W. (1996) · Drugs & Aging · doi:10.2165/00002512-199609020-00001 · Cited by 285
Negative consequences of glycation
Brownlee, M. (2000) · Metabolism · doi:10.1016/s0026-0495(00)80078-5 · Cited by 284
Self-citationMolecular Basis of Arterial Stiffening: Role of Glycation – A Mini-Review
Sell, D. R., & Monnier, V. M. (2012) · Gerontology · doi:10.1159/000334668 · Cited by 282
Pharmacological Inhibition of Diabetic Retinopathy
Kern, T. S., & Engerman, R. L. (2001) · Diabetes · doi:10.2337/diabetes.50.7.1636 · Cited by 277
Forbes, J. M., Cooper, M. E., Thallas, V., Burns, W. C., Thomas, M. C., Brammar, G. C., Lee, F., Grant, S. L., Burrell, L. M., Jerums, G., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.11.3274 · Cited by 277
Amadorins: Novel Post-Amadori Inhibitors of Advanced Glycation Reactions
Khalifah, R. G., Baynes, J. W., & Hudson, B. G. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0371 · Cited by 268
Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy
Hasegawa, G., Nakano, K., Sawada, M., Uno, K., Shibayama, Y., Ienaga, K., & Kondo, M. (1991) · Kidney International · doi:10.1038/ki.1991.308 · Cited by 268
Mechanisms of diabetic vasculopathy: an overview
Cooper, M. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)01323-6 · Cited by 267
Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes
STERN, D., YAN, S., YAN, S., & SCHMIDT, A. (2002) · Ageing Research Reviews · doi:10.1016/s0047-6374(01)00366-9 · Cited by 266
Forbes, J. M., Thallas, V., Thomas, M. C., Founds, H. W., Burns, W. C., Jerums, G., & Cooper, M. E. (2003) · The FASEB Journal · doi:10.1096/fj.02-1102fje · Cited by 263
The role of glycation cross-links in diabetic vascular stiffening
Sims, T. J., Rasmussen, L. M., Oxlund, H., & Bailey, A. J. (1996) · Diabetologia · doi:10.1007/bf00403914 · Cited by 259
SUZUKI, D., MIYATA, T., SAOTOME, N., HORIE, K., INAGI, R., YASUDA, Y., UCHIDA, K., IZUHARA, Y., YAGAME, M., SAKAI, H., et al. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v104822 · Cited by 254
Experimental diabetic neuropathy: an update
Sima, A. A. F., & Sugimoto, K. (1999) · Diabetologia · doi:10.1007/s001250051227 · Cited by 253
Vander Jagt, D. L., & Hunsaker, L. A. (2003) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00212-0 · Cited by 253
Involvement of Hydrogen Peroxide in Collagen Cross-linking by High Glucose in Vitro and in Vivo
Elgawish, A., Glomb, M., Friedlander, M., & Monnier, V. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12964 · Cited by 201
Intervention against the Maillard reaction in vivo
Monnier, V. M. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.014 · Cited by 196
Fernando, D. H., Forbes, J. M., Angus, P. W., & Herath, C. B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205037 · Cited by 184
Protein fructosylation: fructose and the Maillard reaction
Dills, W. (1993) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/58.5.779s · Cited by 171
Kumar Pasupulati, A., Chitra, P. S., & Reddy, G. B. (2016) · Biomolecular Concepts · doi:10.1515/bmc-2016-0021 · Cited by 163
Cavaleri, F., & Bashar, E. (2018) · Journal of Nutrition and Metabolism · doi:10.1155/2018/7195760 · Cited by 126
Coughlan, M. T., Thallas-Bonke, V., Pete, J., Long, D. M., Gasser, A., Tong, D. C. K., Arnstein, M., Thorpe, S. R., Cooper, M. E., & Forbes, J. M. (2007) · Endocrinology · doi:10.1210/en.2006-1300 · Cited by 124
Metadata
- Authors
- Brownlee, M., Vlassara, H., Kooney, A., Ulrich, P., & Cerami, A.
- Venue
- Science
- Published
- 1986-06-27
- Volume
- 232
- Issue
- 4758
- Pages
- 1629-1632
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2032055976
- Cited by
- 1,146
- References
- 22
- FWCI
- 15.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.